0001181431-12-047604.txt : 20120827
0001181431-12-047604.hdr.sgml : 20120827
20120827212932
ACCESSION NUMBER: 0001181431-12-047604
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120823
FILED AS OF DATE: 20120827
DATE AS OF CHANGE: 20120827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christopher Nishan Garabedian
CENTRAL INDEX KEY: 0001492604
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 121058236
MAIL ADDRESS:
STREET 1: 333 RIVER STREET
STREET 2: #303
CITY: HOBOKEN
STATE: NJ
ZIP: 07030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
rrd354490.xml
X0306
4
2012-08-23
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001492604
Christopher Nishan Garabedian
3450 MONTE VILLA PARKWAY, SUITE 101
BOTHELL
WA
98021
1
1
0
0
President and CEO
Stock Option (Right to Buy)
10.08
2012-08-23
4
A
0
150000
0
A
2022-08-23
Common Stock
150000
150000
D
Stock Appreciation Right
10.08
2012-08-23
4
A
0
70000
0
A
2022-08-23
Common Stock
70000
70000
D
25% of the shares subject to the option will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
25% of the shares subject to the stock appreciation right (SAR) will vest and become exercisable on the one (1) year anniversary of August 23, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares will vest and become exercisable in equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Christopher Nishan Garabedian
2012-08-27